Masimo Corporation
MASI
Rang in Aktien
#2169
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Aktienkurs
$179.95
Zuletzt synchronisiert: 2026-06-12
Marktkapitalisierung
$9.42B
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
21.32%
Land
US
Handel Masimo Corporation (MASI)
Kategorie
Healthcare
Umsatz von Masimo Corporation (MASI)
Umsatz im Apr 2026 TTM: $1.56B
Laut den aktuellen Finanzberichten von Masimo Corporation beträgt der derzeitige Umsatz des Unternehmens (TTM) $1.56B. Im Jahr 2023 erzielte das Unternehmen einen Umsatz von $2.05B eine Steigerung gegenüber dem Umsatz im Jahr 2022, der $2.04B betrug. Der Umsatz ist der Gesamtbetrag, den ein Unternehmen durch den Verkauf von Waren oder Dienstleistungen erzielt. Im Gegensatz zum Gewinn werden keine Ausgaben abgezogen.
Umsatzverlauf für Masimo Corporation von 2002 bis 2026
Umsatz am Ende jedes Jahres
| Jahr | Umsatz | ändert |
|---|---|---|
| 2026 (TTM) | $1.56B | -25.59% |
| 2024 | $2.09B | 2.26% |
| 2023 | $2.05B | 0.60% |
| 2022 | $2.04B | 64.28% |
| 2021 | $1.24B | 8.35% |
| 2020 | $1.14B | 21.95% |
| 2019 | $937.84M | 9.27% |
| 2018 | $858.29M | 8.61% |
| 2017 | $790.25M | 10.85% |
| 2016 | $712.90M | 13.14% |
| 2015 | $630.11M | 7.41% |
| 2014 | $586.64M | 7.20% |
| 2013 | $547.25M | 10.95% |
| 2012 | $493.23M | 12.36% |
| 2011 | $438.99M | 8.28% |
| 2010 | $405.41M | 16.12% |
| 2009 | $349.12M | 13.69% |
| 2008 | $307.07M | 19.82% |
| 2007 | $256.29M | 14.24% |
| 2006 | $224.34M | 107.93% |
| 2005 | $107.89M | 55.56% |
| 2004 | $69.36M | 48.41% |
| 2003 | $46.73M | 20.35% |
| 2002 | $38.83M | 0.00% |
Umsatz vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Umsatz | Umsatzunterschied | Land |
|---|---|---|---|
| $46.59B | 2,889.09% |
US
|
|
| $35.48B | 2,176.80% |
IE
|
|
| $25.84B | 1,557.81% |
US
|
|
| $21.00B | 1,247.19% |
US
|
|
| - | - |
DE
|
